Learn More
Medchemexpress LLC 1H,5H-Imidazo[1,2-a]pyrrolo[1,2-d]pyrazin-5-one, 2,3,10,10a-tetrahydro-1-[(3-methyl-4-isoxazolyl)carbonyl]-10a-(6-methyl-3-pyridinyl)-, (10aS)- | 1323077-88-8 | 99.7% | 377.40 | 1 MG

Supplier: Medchemexpress LLC HY109004A50MG
Enzaplatovir (BTA-C585) is an orally bioavailable inhibitor for respiratory syncytial virus (RSV) infection and is described as a small-molecule RSV entry inhibitor. It is used for respiratory syncytial virus (RSV) infection and is relevant for RSV-associated lower respiratory tract infection (LRTI).
- Orally bioavailable
- Inhibitor for respiratory syncytial virus (RSV) infection
- Small-molecule RSV entry inhibitor
- Used for respiratory syncytial virus infection
- Relevant for RSV-associated lower respiratory tract infection (LRTI)
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.